You just read:

Large Clinical Study Demonstrates High Detection Rate and Ability to Monitor KRAS Mutations in Pancreatic Cancer Patients; Results Presented at 2016 AACR Pancreatic Cancer Meeting

News provided by

Trovagene, Inc.

May 13, 2016, 08:05 ET